DNA surface modified gadolinium phosphate nanoparticles as MRI contrast agents.

Area of Science:

• Nanotechnology
• Materials Science
• Biomedical Engineering

Background:

• Gadolinium phosphate (GdPO4·H2O) nanoparticles were synthesized for potential use as MRI contrast agents.
• Surface modification with oligonucleotides was explored to enhance nanoparticle functionality.
• The study aimed to evaluate the MRI relaxivity properties of these modified nanoparticles.

Purpose of the Study:

• To synthesize and characterize oligonucleotide-modified gadolinium phosphate nanoparticles.
• To assess the magnetic resonance relaxivity (r1, r2) of these nanoparticles.
• To determine if biofunctionalization affects their performance as MRI contrast agents.

Main Methods:

• GdPO4·H2O nanoparticles (50-100 nm) were synthesized via microemulsion.
• Particles were surface-modified with 5'-phosphate terminated oligonucleotides.
• Magnetic resonance relaxivity measurements were performed at 14.1 T, comparing with commercial agents.

Main Results:

• Synthesized nanoparticles exhibited good dispersibility and stability in water.
• Oligonucleotide modification demonstrated specific interaction with Gd(3+) sites.
• GdPO4·H2O nanoparticles showed relaxivities comparable to Feridex and Omniscan.

Conclusions:

• Oligonucleotide-modified GdPO4·H2O nanoparticles function as effective MRI contrast agents.
• Surface biofunctionalization does not impede their MRI contrast capabilities.
• These findings support the development of functionalized nanoparticles for advanced medical imaging.